Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 15, Number 2—February 2009

Research

Prospective Surveillance of Invasive Group A Streptococcal Disease, Fiji, 2005–2007

Andrew C. SteerComments to Author , Adam Jenney, Joseph Kado, Michael F. Good, Michael Batzloff, Lepani Waqatakirewa, E. Kim Mullholland, and Jonathan R. Carapetis
Author affiliations: University of Melbourne, Melbourne, Victoria, Australia (A.C. Steer, A. Jenney, E.K. Mullholland, J.R. Carapetis); Ministry of Health, Suva, Fiji (J. Kado, L. Waqatakirewa); Queensland Institute of Medical Research, Brisbane, Queensland, Australia (M.F. Good, M. Batzloff); London School of Hygiene and Tropical Medicine, London, UK (E.K. Mullholand); Menzies School of Health Research, Casuarina, Northern Territory, Australia (J.R. Carapetis)

Main Article

Table 2

Clinical signs and symptoms in patients with invasive GAS infection, by age, Fiji, 2005–2007

Clinical signs/symptoms No. patients by age group
Total no. (%) patients
0–14 y 15–49 y >50 y
Soft tissue infection 2 9 12 23 (38)
Bacteremia with no clinical focus 5 5 7 17 (28)
Septic arthritis 2 1 5 8 (13)
Necrotizing fasciitis 2 2 4 (7)
Pneumonia 2 2 4 (6)
Gynecologic infection 1 1 2 (3)
Osteomyelitis 1 1 (2)
Peritonitis


1
1 (2)
Total no. (%) patients 12 (20) 18 (30) 30 (50) 60

*GAS, group A streptococci.

Main Article

TOP